Medicine & Life Sciences
Ergosterol
97%
Advanced Glycation End Products
83%
PPAR gamma
76%
Receptor for Advanced Glycation End Products
71%
Fibrosis
51%
Up-Regulation
49%
Liver
35%
Matrix Metalloproteinase 9
29%
Smooth Muscle
24%
Actins
23%
Protective Agents
18%
Cohort Effect
18%
NADPH Oxidases
15%
Epithelial-Mesenchymal Transition
14%
Vimentin
14%
Cadherins
13%
Metabolic Syndrome
12%
Reactive Oxygen Species
11%
Agriculture & Biology
advanced glycation end products
100%
peroxisome proliferator-activated receptor gamma
94%
ergosterol
81%
liver
40%
gelatinase B
33%
receptors
31%
smooth muscle
22%
cells
21%
actin
21%
metabolic syndrome
15%
cadherins
15%
vimentin
14%
NAD(P)H oxidase (H2O2-forming)
13%
reactive oxygen species
9%
assays
6%